Trial Search

Current Search Criteria:

Intervention: XR-TPM (Trokendi XR)
Found 7 matching trials

A Placebo-Controlled Study of Mixed Amphetamine Salts and Topiramate for the Treatment of Cocaine Dependence

PHASE2

The proposed protocol is a double-blind, placebo-controlled outpatient stud...

Status

Completed

Location

STARS

Start Date

2007-02

Trial ID

NCT00421603

Treatments Being Tested

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight

PHASE3

A phase 3, multicenter, randomized, double-blind, double-dummy, parallel-gr...

Status

Withdrawn

Location

Eurofarma Laboratórios S.A

Start Date

2026-04

Trial ID

NCT05209984

Phentermine/Topiramate for Uric Acid Stones

PHASE2

The investigator proposes an 18 month, feasibility pilot study, randomizing...

Status

Completed

Location

University of Florida

Start Date

2021-03-31

Trial ID

NCT04621929

Therapy for Migraine Prevention in Children 6-11 Years of Age

PHASE4

The aim of this study is to evaluate the effect of SPN-538 for the prophyla...

Status

Terminated

Location

CNS Healthcare

Start Date

2020-07-14

Trial ID

NCT04050293

Treatments Being Tested

Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity

PHASE4

Researchers are doing this study to compare the effects of drugs approved f...

Status

Completed

Location

Novo Nordisk Investigational Site

Start Date

2019-01-07

Trial ID

NCT03799198

Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine

PHASE2

Crossover, randomized, double blind: Q12h dosing in both periods; matching ...

Status

Withdrawn

Location

University of Minnesota

Start Date

2017-10-30

Trial ID

NCT03280342

Anti-obesity Pharmacotherapy and Inflammation

N/A

This study evaluates the relationship between weight loss, circulating infl...

Status

Active Not Recruiting

Location

LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO

Start Date

2023-06-01

Trial ID

NCT05756764